Trial Profile
A Prospective Randomized Open-Label Study on the Efficacy and Safety of Intermittent Preventive Treatment in Pregnancy (IPTp) With Dihydroartemisinin-Piperaquine (DP) Versus IPTp With Sulfadoxine-Pyrimethamine (SP) in Malawi
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Nov 2022
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; Pyrimethamine/sulfadoxine
- Indications Malaria
- Focus Therapeutic Use
- Acronyms STOPMIP-MW
- 03 Jul 2021 Results of an analysis of a cohort of infant born to mothers randomized assessing the effect of intermittent preventive treatment of malaria during pregnancy and placental malaria on time to first malaria episode and P.falciparum incidence published in the Journal of Infectious Diseases
- 19 Aug 2020 Status changed from active, no longer recruiting to completed.
- 19 Oct 2018 Status changed from recruiting to active, no longer recruiting.